ODE II director
This article was originally published in The Tan Sheet
Executive Summary
FDA names Curtis Rosebraugh director of the Office of Drug Evaluation II after nine months as acting director of the office in the Center for Drug Evaluation and Research. He will oversee the divisions of Anesthesia, Analgesia and Rheumatology Products, Metabolism and Endocrinology Products and Pulmonary and Allergy Products. Rosebraugh from 2003-2005 served as deputy director of the Office of Nonprescription Products, with responsibilities including acting director of ONP's Division of Nonprescription Clinical Evaluation (1"The Tan Sheet" Feb. 10, 2003, In Brief). In 2005 he was named deputy director of the ODE II and became acting director in September 2007...